Thierer, J. (2016). LEADER Trial: Liraglutide reduces mortality in patients with type 2 diabetes. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016 [Epub ahead of print]. Sociedad Argentina de Cardiología.
Chicago-Zitierstil (17. Ausg.)Thierer, Jorge. LEADER Trial: Liraglutide Reduces Mortality in Patients with Type 2 Diabetes. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Et Al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016 [Epub Ahead of Print]. Sociedad Argentina de Cardiología, 2016.
MLA-Zitierstil (9. Ausg.)Thierer, Jorge. LEADER Trial: Liraglutide Reduces Mortality in Patients with Type 2 Diabetes. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Et Al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016 [Epub Ahead of Print]. Sociedad Argentina de Cardiología, 2016.